A new randomized clinical trial suggests that singing therapy provides greater short-term symptom relief and improved quality of life compared to diaphragmatic breathing exercises for people with supragastric belching. Structured singing therapy also resulted in higher response rates and more enjoyable experiences among patients.
SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateJul 22, 2026
The study demonstrated sustained improvements in disease features in mouse models with effects lasting throughout their lifespan. Genespire's approach has the potential to translate into human health as a single-administration treatment for patients with MMA.
SourceFondazione Telethon·JournalJournal of Hepatology·TypeExperimental study·DateJul 8, 2026
Malcom Brenner, a renowned physician-scientist, will lead the new center. He brings expertise in cell and gene therapy to advance therapies for various diseases.
The center is the first in the region to offer TCR-T therapy, an FDA-approved treatment targeting proteins inside cancer cells. Patients with chemotherapy-resistant synovial sarcoma can now access this novel cellular therapy.
SourceUniversity of Maryland School of Medicine·DateJun 3, 2026
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A new study by the American Society of Hematology finds that stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults. Gene therapy, while promising, comes with an astronomical cost and requires a significant price reduction to be competitive.
SourceAmerican Society of Hematology·JournalBlood·DateJun 2, 2026
A new machine-learning model uses pre-therapy PET/CT scans to estimate radiation dose to tumors and healthy organs, improving patient selection and reducing toxicity risk. The study's findings suggest a promising ability to predict post-therapy dosimetry, which may optimize treatment plans for individual patients.
SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateMay 30, 2026
Odylia Therapeutics is advancing a gene therapy treatment for Usher Syndrome Type 1C (USH1C)-associated vision loss, a rare autosomal recessive disorder. The grant will support the development of an investigational USH1C gene therapy designed to restore or preserve vision.
A new international study shows that gene therapy targeting the OTOF gene successfully restored hearing in most participants, with significant improvements in speech perception and language skills. The treatment remained safe and effective for up to 2.5 years, offering new hope for individuals with inherited deafness.
SourceMass Eye and Ear·JournalNature·TypeRandomized controlled/clinical trial·DateApr 22, 2026
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Researchers modeled gene drive dynamics in plants and found that seed banks can hinder the spread of genetic changes. The simulations suggest that proper consideration is needed to mitigate the impact of stored seeds on the gene drive's success.
SourceCornell University·JournalNature Plants·DateApr 3, 2026
Mohamed Abou-el-Enein, a USC physician-scientist, has received the Outstanding New Investigator Award and Best of Molecular Therapy Award from the American Society of Gene + Cell Therapy. His work focuses on translating scientific discoveries into clinical applications, with a particular emphasis on cell therapies.
A new study shows that PSMA therapy can delay the need for hormone therapy in prostate cancer patients by an average of 20 months. The therapy is effective in earlier stages of the disease, improving survival and quality of life for approximately two out of three patients.
SourceRadboud University Medical Center·JournalThe Lancet Oncology·TypeRandomized controlled/clinical trial·DateMar 30, 2026
The FDA has approved a gene therapy for severe leukocyte adhesion deficiency-I, a rare genetic condition that affects one in a million children globally. The therapy, Kresladi, has been shown to significantly reduce severe infections and improve immune function in treated patients.
SourceUniversity of California - Los Angeles Health Sciences·DateMar 27, 2026
The company's ATA-200 gene therapy has shown safety, pharmacodynamics, and efficacy results in the first patients treated, offering hope for children with LGMD-R5. The therapy delivers a normal copy of the γ-sarcoglycan gene and has been awarded Orphan Drug Designation in the US and Europe.
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers at the University of Basel have developed a gene therapy that can potentially treat LAMA2-related muscular dystrophy, a rare and fatal muscle disease in children. The therapy has been shown to stabilize muscles and nerves and halt disease progression in animal models, with a single treatment being sufficient.
SourceUniversity of Basel·JournalMolecular Therapy·DateFeb 26, 2026
A large Danish study found that menopausal hormone therapy is not associated with an increased risk of death in women with moderate to severe symptoms and no contraindications. The study also showed a significant survival benefit for women who had undergone bilateral oophorectomy after using hormone therapy.
SourceBMJ Group·JournalThe BMJ·TypeObservational study·DateFeb 18, 2026
UCLA researchers have developed a novel gene-editing approach using lipid nanoparticles to deliver a full-length CFTR gene into human airway cells. The study shows promise for treating cystic fibrosis by correcting the underlying genetic mutation, which could lead to more effective and long-term therapies.
SourceUniversity of California - Los Angeles Health Sciences·JournalAdvanced Functional Materials·DateFeb 17, 2026
A bibliometric analysis of global advances in cell and gene therapy reveals uneven progress, with US and China leading the field. Japan's contributions are significant but lack qualitative influence.
SourceKyoto University·JournalCytotherapy·TypeData/statistical analysis·DateFeb 12, 2026
A new study by Mass General Brigham highlights the efficacy of proton therapy in achieving excellent tumor control rates while minimizing side effects compared to traditional radiotherapy. Proton therapy limits radiation exposure to healthy tissue, potentially preserving cognition and hormone function.
SourceMass General Brigham·JournalNeuro-Oncology·TypeRandomized controlled/clinical trial·DateFeb 11, 2026
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
Researchers at the University of California - San Diego have developed a new method to improve gene therapy by increasing the efficacy of gene delivery while minimizing harmful side effects. The new workflow allows for increased control of nuclear DNA delivery, with greater than tenfold increase in nuclear DNA delivery observed.
SourceUniversity of California - San Diego·JournalNature Communications·TypeExperimental study·DateFeb 4, 2026
Researchers developed AAVLINK, harnessing Cre/lox-mediated intermolecular DNA recombination to enable in vivo reassembly of large genes. The method achieves high-efficiency full-length gene reconstitution and significantly improves therapeutic outcomes in animal models.
SourceChinese Academy of Sciences Headquarters·JournalCell·DateFeb 3, 2026
The AAVLINK method harnesses Cre/lox-mediated intermolecular DNA recombination to enable efficient full-length gene reconstitution and robust expression of therapeutic genes. This approach overcomes the limited packaging capacity of adeno-associated viruses, offering a strategy for delivering large gene cargoes in gene therapy.
SourceShenzhen Institute of Advanced Technology, Chinese Academy of Sciences·DateJan 27, 2026
Pompe disease is a rare genetic disorder caused by a deficiency in the GAA enzyme, leading to glycogen accumulation in cells. Genethon's gene therapy approach has shown preclinical efficacy in animal studies, correcting glycogen accumulation and improving cardiac hypertrophy and muscular dysfunction.
A Phase III trial has demonstrated the survival benefit of proton therapy compared to traditional radiation therapy for oropharyngeal cancer patients, with improved overall survival at five years. Proton therapy also resulted in reduced toxicities and feeding tube dependence, highlighting its potential as a standard treatment option.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateDec 11, 2025
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Waskyra, an ex vivo gene therapy, offers new hope for patients with Wiskott-Aldrich syndrome by reducing severe bleeding events and serious infections. The FDA approval confirms Fondazione Telethon's excellence in rare genetic disease research.
Fondazione Telethon's gene therapy Waskyra, treating Wiskott-Aldrich Syndrome, has received CHMP positive opinion and marketing authorisation in the European Union. The therapy offers new hope for patients affected by this rare genetic disorder.
Researchers at Weill Cornell Medicine have developed a powerful new gene-switch tool called Cyclone, which allows scientists to turn on or off target genes with precision. The tool uses a non-toxic molecule acyclovir to suppress gene activity, and has the potential to be adopted throughout biomedical research and gene therapies.
SourceWeill Cornell Medicine·JournalNature Methods·DateNov 3, 2025
International experts have established guidelines for gene therapy in hereditary hearing loss, emphasizing patient-centered care and respect for diversity. The guidelines outline frameworks for clinical trials, including patient selection criteria, surgical procedures, and safety evaluations.
SourceCell Press·JournalMed·TypeCommentary/editorial·DateOct 23, 2025
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
A landmark study published in the New England Journal of Medicine reports the long-term safety and efficacy of gene therapy for children with ADA-SCID, a rare immune disorder. The treatment resulted in a 100% survival rate and over 95% cure rate, with patients able to respond to routine childhood vaccinations.
SourceUniversity College London·JournalNew England Journal of Medicine·TypeObservational study·DateOct 15, 2025
A new gene therapy has restored and maintained immune system function in 59 of 62 children born with ADA-SCID, a rare genetic immune disorder. The treatment involves delivering a healthy copy of the ADA gene to patients' blood stem cells, allowing them to produce healthy immune cells capable of fighting infections.
SourceUniversity of California - Los Angeles·JournalNew England Journal of Medicine·DateOct 15, 2025
Gene therapy offers new hope for hereditary deafness, while precision surgical techniques improve cancer outcomes. The AAO-HNSF 2025 Annual Meeting also highlighted access to specialized ENT care, with key strategies for workforce planning and efficient care delivery models.
SourceAmerican Academy of Otolaryngology - Head and Neck Surgery·DateOct 13, 2025
Researchers developed a new gene therapy that reversed symptoms related to SYNGAP1-related disorders in mice, including intellectual disability, epilepsy, and risk-taking behaviors. The therapy successfully delivered a working copy of the SYNGAP1 gene into brain cells using an adeno-associated virus, offering hope for treatment in humans.
SourceAllen Institute·JournalMolecular Therapy·TypeExperimental study·DateOct 9, 2025
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
New research shows that music therapy significantly decreases heart rate, systolic blood pressure, and patient-ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU). Music therapy is a safe, low-cost, non-pharmacological intervention that complements conventional treatments.
A UCLA research team led by Dr. Donald Kohn has developed a one-time stem cell gene therapy treatment for alpha thalassemia major that could be curative. The therapy involves adding the missing alpha-globin gene to patient cells using a viral vector, enabling them to produce functional hemoglobin.
SourceUniversity of California - Los Angeles·JournalCell Reports Medicine·TypeExperimental study·DateSep 17, 2025
A KAIST research team has developed a universal technology that identifies gene control targets in altered cellular gene networks and restores them. By applying an algebraic approach, they can quickly and accurately calculate how the overall cellular response would change if a specific gene were controlled.
SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalScience Advances·TypeMeta-analysis·DateAug 29, 2025
A study published in the Journal of Hepatology reveals that only 15-20% of neonatal liver cells are responsible for generating over 90% of the adult liver mass. This finding has major implications for pediatric gene therapy, allowing scientists to achieve more effective and durable correction of inherited liver diseases.
SourceFondazione Telethon·JournalJournal of Hepatology·TypeExperimental study·DateAug 28, 2025
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
A key contributor is the lab of Prof. Ayal Hendel at Bar-Ilan University's Goodman Faculty of Life Sciences, focusing on evaluating CRISPR-based gene editing precision and safety. The project aims to decentralize CAR-T cell therapy production, making it available to more patients by reducing costs and increasing accessibility.
University of Iowa researchers have successfully tested a technique that stimulates a gene to prevent craniosynostosis, a condition causing infants' skulls to close prematurely. The treatment involved injecting nano-sized packets containing the miR-200a gene into newborn mice, allowing their brains to expand and preventing skull fusion.
SourceUniversity of Iowa·JournalScience Advances·TypeExperimental study·DateAug 26, 2025
Researchers used human stem cell-derived kidney organoids to test the safety of gene editing delivered by AAV, a common tool in clinical trials. The study found that AAV2 caused significant harm to kidney cells through the NFκB pathway, but an existing drug was able to prevent this damage without interfering with gene delivery.
SourceMassachusetts General Hospital·JournalSignal Transduction and Targeted Therapy·TypeExperimental study·DateAug 18, 2025
Researchers developed a one-time gene editing treatment that restored hearing and balance in adult mice with DFNA41, a genetic form of progressive deafness. The therapy successfully disabled the harmful mutation while preserving the normal gene, leading to long-term hearing and balance restoration.
SourceMass Eye and Ear·JournalJournal of Clinical Investigation·TypeExperimental study·DateAug 14, 2025
A Delphi exercise with 41 therapists identified 27 statements about therapy that can improve sessions, including the importance of teamwork, outside work, and discussing concerns with loved ones. An app called EveryStep is being trialed to prepare patients for therapy, offering daily activities to aid engagement.
SourceUniversity of Warwick·JournalBMJ Open·TypeExperimental study·DateAug 6, 2025
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
Researchers at St. Jude Children's Research Hospital identified virtual memory T cells, a specialized group of immune cells, which provide nonspecific immunity for infants early in life. These cells are a bridge between innate and adaptive immunity, allowing the adaptive immune system time to develop true memory.
SourceSt. Jude Children's Research Hospital·JournalImmunity·TypeExperimental study·DateJul 31, 2025
Researchers at the Korea Institute of Science and Technology (KIST) have developed a high-throughput multiplexed gene and cell doping analysis technique using CRISPR-Cas technology. This breakthrough offers superior performance in detecting exogenous genes, demonstrating potential applications in sports ethics and fairness, as well as ...
SourceNational Research Council of Science & Technology·JournalScience Advances·DateJul 30, 2025
Genethon is launching a Phase 3 clinical trial in Europe for its low-dose microdystrophin gene therapy GNT0004, targeting boys aged 6 to 10 with retained walking ability. The trial aims to demonstrate efficacy and tolerance of the treatment.
A multicenter clinical trial found gene therapy safe and effective for both children and adults with hereditary deafness. The treatment restores hearing within one month of delivery, showing potential for fast results in addressing congenital deafness and other forms of hearing loss.
SourceUniversity of California - Irvine·JournalNature Medicine·DateJul 22, 2025
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
A new route of delivering gene therapy is being explored, potentially reducing invasiveness and increasing accessibility. Researchers will test a novel approach on non-human primates, aiming to expand access to office-based treatments.
SourceUniversity of California - Davis Health·DateJul 22, 2025
Gene therapy relies on efficient and safe delivery of therapeutic genes to target cells. Macromolecular carriers, including synthetic and natural polymers, offer biocompatibility, controlled release, and targeted delivery. These systems have shown promise in treating genetic disorders and complex diseases like cancer.
SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateJul 14, 2025
A new study conducted at Karolinska Institutet reports that gene therapy improved hearing in all ten patients with congenital deafness or severe hearing impairment. The treatment was well-tolerated and showed remarkable results, with the majority of patients recovering some hearing after just one month.
SourceKarolinska Institutet·JournalNature Medicine·TypeExperimental study·DateJul 2, 2025
A new study by the NIH found that hormone therapy may alter breast cancer risk in women under 55. Women treated with unopposed estrogen hormone therapy were less likely to develop breast cancer, while those using estrogen plus progestin hormone therapy were more likely to develop the disease.
SourceNIH/Office of the Director·JournalThe Lancet Oncology·DateJun 30, 2025
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Gene therapy has been shown to significantly improve blood flow in the brains of patients with sickle cell disease, decreasing the risk of stroke. The treatment has a more substantial and long-lasting protective effect than other treatments like hydroxyurea or blood transfusions.
SourceSt. Jude Children's Research Hospital·JournalAmerican Journal of Hematology·DateJun 27, 2025
Researchers have developed a gene therapy that targets the root cause of Alzheimer's disease, influencing brain cell behavior to preserve cognitive function. Delivering the treatment at the symptomatic stage preserved hippocampal-dependent memory and altered gene expression in mice, suggesting potential to restore brain health.
SourceUniversity of California - San Diego·JournalSignal Transduction and Targeted Therapy·DateJun 5, 2025
Scientists at San Raffaele Telethon Institute for Gene Therapy discovered that CRISPR-Cas9 gene editing can cause inflammation and senescence-like responses in blood stem cells. This reduces the cells' ability to regenerate blood cells after transplantation, limiting the long-term success of gene therapy.
SourceFondazione Telethon·JournalCell Reports Medicine·TypeExperimental study·DateJun 3, 2025
A team of scientists from SR-Tiget has identified a unique window shortly after birth to deliver lentiviral vectors directly into the bloodstream, enabling gene transfer and long-term engraftment. This approach shows promise for treating some genetic blood disorders without stem cell transplantation or chemotherapy.
SourceFondazione Telethon·JournalNature·TypeExperimental study·DateMay 28, 2025
A Kobe University study finds that a gene regulating root development in vascular plants is also essential for organ development in liverworts, demonstrating the evolutionary dynamic of co-opting. The RLF protein, involved in this process, interacts with others to clarify plant organ development evolution.
SourceKobe University·JournalNew Phytologist·TypeExperimental study·DateMay 25, 2025
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Researchers developed a gene therapy that can target the airway and lungs using a nasal spray, outperforming previous versions in preclinical models. The innovative tool, AAV.CPP.16, showed promise for treating respiratory diseases like pulmonary fibrosis and viral infections.
SourceMass General Brigham·JournalCell Reports Medicine·TypeExperimental study·DateMay 22, 2025
A child diagnosed with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy, showcasing the power of tailored gene editing to treat patients. The infant is now growing well and thriving after receiving three doses of the therapy with no serious side effects.
SourceChildren's Hospital of Philadelphia·JournalNew England Journal of Medicine·TypeCase study·DateMay 15, 2025
A team of researchers has successfully treated an infant with a life-threatening, incurable genetic disease using personalized gene editing therapy. The infant, who was diagnosed shortly after birth, showed positive responses to the treatment and improved symptoms over time.
SourceNIH/Office of the Director·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMay 15, 2025
The evoCAST system enables precise insertion of entire genes into the human genome, overcoming a major challenge in gene therapy. This breakthrough could lead to more reliable treatments for diseases like cystic fibrosis and hemophilia.
SourceColumbia University Irving Medical Center·JournalScience·DateMay 15, 2025
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
The AAN has issued an Evidence in Focus article on delandistrogene moxeparvovec, a gene therapy approved by the FDA for Duchenne muscular dystrophy. The therapy may slow motor function decline but its long-term effectiveness and safety are still uncertain.
SourceAmerican Academy of Neurology·JournalNeurology·DateMay 14, 2025
Researchers from The University of Osaka developed a new technique using mass photometry to detect and quantify components of rAAV particles. This method can distinguish between full and empty particles, streamlining gene therapy manufacturing and improving clinical effectiveness.
SourceThe University of Osaka·JournalAnalytical Chemistry·TypeExperimental study·DateMay 12, 2025
Researchers from Mass General Brigham presented key findings from multiple innovative studies on gene and cell therapy, focusing on rare diseases, brain cancer, and neurodegenerative disorders. The studies explored strategies to improve care delivery and accelerate translation from lab to clinic, with potential breakthroughs in treatin...